-transparent.png){kind=logo}
A 52-year-old man developed therapy-related acute myeloid leukemia (AML) following prolonged immunosuppression with azathioprine for polymyositis. Karyotypic analysis showed deletions of the short arm of chromosome 7 and the long arm of chromosome 5. The importance of recognizing this potential complication while treating benign rheumatological and immunological diseases with purine analogues like azathioprine is emphasized. Therapy-related AML is a poor prognostic group that does not respond favourably to standard induction therapy.
Related Publications
K Krishnan, and
P Adams, and
S Silveira, and
S Sheldon, and
L Dabich
March 1977,
Postgraduate medical journal,
K Krishnan, and
P Adams, and
S Silveira, and
S Sheldon, and
L Dabich
March 2010,
The Journal of rheumatology,
K Krishnan, and
P Adams, and
S Silveira, and
S Sheldon, and
L Dabich
February 1995,
Annals of the rheumatic diseases,
K Krishnan, and
P Adams, and
S Silveira, and
S Sheldon, and
L Dabich
October 1973,
Archives of internal medicine,
K Krishnan, and
P Adams, and
S Silveira, and
S Sheldon, and
L Dabich
November 1990,
Lancet (London, England),
K Krishnan, and
P Adams, and
S Silveira, and
S Sheldon, and
L Dabich
October 1988,
European journal of pediatrics,
K Krishnan, and
P Adams, and
S Silveira, and
S Sheldon, and
L Dabich
February 2014,
British journal of haematology,
K Krishnan, and
P Adams, and
S Silveira, and
S Sheldon, and
L Dabich
May 2016,
Nature reviews. Clinical oncology,
K Krishnan, and
P Adams, and
S Silveira, and
S Sheldon, and
L Dabich
July 2005,
British journal of haematology,
K Krishnan, and
P Adams, and
S Silveira, and
S Sheldon, and
L Dabich
January 2011,
Srpski arhiv za celokupno lekarstvo,
